NHS Approves First Licensed Vitiligo Cream, Historic Milestone
Ruxolitinib cream, sold as Opzelura, has been approved for NHS use in England, marking the first licensed treatment for vitiligo, a chronic skin condition affecting one in 100 people in the UK.


